Skip to content

Clinical trials

Completed Carcinoma, Medullary trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Status: Completed Country / region: South Korea Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20111
20171
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Pharmaceuticals1
Exelixis1
Genzyme, a Sanofi Company1
Hoffmann-La Roche1
Sanofi1
Yonsei University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary6
Thyroid Neoplasms4
Carcinoma, Non-Small-Cell Lung2
Head and Neck Neoplasms2
Multiple Endocrine Neoplasia Type 2a2
Thyroid Cancer, Papillary2
Adenocarcinoma1
Adenocarcinoma, Follicular1
Adenocarcinoma, Papillary1
Bronchial Neoplasms1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.